The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities - Quiz - MDSpire

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

  • By

  • Zhennan Ma

  • Xiuqing Gong

  • Fuquan Liu

  • May 28, 2026

  • 0 min

Share

Original Source(s)

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

  • by Zhennan Ma, Xiuqing Gong, Fuquan Liu

  • May 28, 2026

Related Content

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

High-grade astrocytoma with piloid features: a case report of comprehensive management